|View printer-friendly version|
|July 17, 2007 1:52 p.m.|
|Teva To Report Second Quarter 2007 Financial Results On August 1, 2007|
CONFERENCE CALL SCHEDULED FOR 8:30 AM ETJerusalem, Israel, July 17, 2007 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its second quarter 2007 financial results on Wednesday, August 1, 2007.
Teva will host a conference call and live webcast on that same day, at 08:30AM ET to discuss its second quarter 2007 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva's web site at www.tevapharm.com prior to the call.
Investors and other interested parties may access a live webcast through Teva's web site at www.tevapharm.com. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Following the conclusion of the call, a replay of the webcast will be available within 24 hours at the Company's web site. Alternatively, a replay of the call can be accessed until August 8, 2007 at 11:59 (ET), by calling 1-(201) 612-7415 outside the U.S. or 1-(877) 660-6853 in the U.S. The Pass Code to access the replay is: Account #3055 and Conference ID #248467.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 76% of Teva's sales are in North America and Europe.